Current understanding of the impact of COVID-19 on gastrointestinal disease: Challenges and openings
Tarun Sahu, Arundhati Mehta, Yashwant Kumar Ratre, Akriti Jaiswal, Naveen Kumar Vishvakarma, L.V.K.S. Bhaskar, Henu Kumar Verma
Abstract
were also found to be highly expressed in gastrointestinal epithelial cells of the intestinal mucosa. Furthermore, SARS-CoV-2 can dynamically infect and replicate in both GI and liver cells. Taken together these results indicate that the GI tract is a potential target of SARS-CoV-2. Therefore, the present review summarizes the vital information available to date on COVID-19 and its impact on GI aspects.
Topics & Concepts
MedicineAsymptomaticGastroenterologyCoronavirusAbdominal painCoronaviridaeVomitingDiarrheaInternal medicineNauseaVirologyDiseaseCoronavirus disease 2019 (COVID-19)ImmunologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesLong-Term Effects of COVID-19COVID-19 and healthcare impacts